Analyzing the MIF protein level, we did not find any significant correlation between baseline values and depression severity at follow-up three weeks after inclusion (HAM-D, MADRS, BDI-II) in the total, sex-specific, and pre- or unmedicated cohorts (Table 3). Here, MIF is linked to depressive symptom measurement.